1332140007: Foscarbidopa (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\Antiparkinsonian agent (substance)\...

\Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action (substance)\Foscarbidopa

\Dihydroxyphenylalanine\Foscarbidopa

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Foscarbidopa

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Foscarbidopa

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-May 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

5349009019 Foscarbidopa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

5349010012 Foscarbidopa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Foscarbidopa	Is a	Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action (substance)	true	Inferred relationship	Some
Foscarbidopa	Is a	Dihydroxyphenylalanine	true	Inferred relationship	Some
Foscarbidopa	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Dopamine receptor agonist (disposition)	true	Inferred relationship	Some
Foscarbidopa	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Dihydroxyphenylalanine decarboxylase inhibitor (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely foscarbidopa 12 milligram/1 milliliter and foslevodopa 240 milligram/1 milliliter conventional release solution for infusion (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Foscarbidopa	Inferred relationship	Some	2
Product containing precisely foscarbidopa 12 milligram/1 milliliter and foslevodopa 240 milligram/1 milliliter conventional release solution for infusion (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Foscarbidopa	Inferred relationship	Some	2
Product containing only foscarbidopa and foslevodopa in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Foscarbidopa	Inferred relationship	Some	2
Product containing foscarbidopa and foslevodopa in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Foscarbidopa	Inferred relationship	Some	2
Product containing only foscarbidopa and foslevodopa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Foscarbidopa	Inferred relationship	Some	2
Foscarbidopa- and foslevodopa-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Foscarbidopa	Inferred relationship	Some	2
Foscarbidopa-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Foscarbidopa	Inferred relationship	Some	1

This concept is not in any reference sets